BECN1 and neurodegenerative disease: Interestingly, other BECN1 activators, such as Tat‐BECN1 and Isorhynchophylline, have also been identified to play a neuroprotective role in preclinical studies, which indicates the great potential of BECN1‐depedent autophagy in treatment of neurodegenerative diseases.